At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention.
At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention.
复制标题
DOI:
10.3390/cancers13194852
复制
发表时间:
2021-09-28
期刊:
影响因子:
5.2
通讯作者:
Marini S
中科院分区:
文献类型:
--
作者:
Tundo GR;Sbardella D;Oddone F;Kudriaeva AA;Lacal PM;Belogurov AA Jr;Graziani G;Marini S
Immunoproteasome plays a key role in the generation of antigenic peptides. Immune checkpoints therapy is a front-line treatment of advanced/metastatic tumors, and to improve its efficacy, a broader knowledge of the dynamics of antigen repertoire processing by cancer cells is mandatory. The scope of this review is to offer a picture of the role of immunoproteasome in antigen presentation to fuel the hypothesis of novel therapeutic interventions based on the modulation of this proteolytic complex and immune checkpoints. Immunoproteasome is a noncanonical form of proteasome with enzymological properties optimized for the generation of antigenic peptides presented in complex with class I MHC molecules. This enzymatic property makes the modulation of its activity a promising area of research. Nevertheless, immunotherapy has emerged as a front-line treatment of advanced/metastatic tumors providing outstanding improvement of life expectancy, even though not all patients achieve a long-lasting clinical benefit. To enhance the efficacy of the currently available immunotherapies and enable the development of new strategies, a broader knowledge of the dynamics of antigen repertoire processing by cancer cells is needed. Therefore, a better understanding of the role of immunoproteasome in antigen processing and of the therapeutic implication of its modulation is mandatory. Studies on the potential crosstalk between proteasome modulators and immune checkpoint inhibitors could provide novel perspectives and an unexplored treatment option for a variety of cancers.
登录
查看更多内容
DOI:
10.1096/fj.14-259333
发表时间:
2015-05
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
Belogurov A Jr;Kuzina E;Kudriaeva A;Kononikhin A;Kovalchuk S;Surina Y;Smirnov I;Lomakin Y;Bacheva A;Stepanov A;Karpova Y;Lyupina Y;Kharybin O;Melamed D;Ponomarenko N;Sharova N;Nikolaev E;Gabibov A
通讯作者:
Gabibov A
影响因子:
5.2
作者:
Atkinson, Stuart P.;Collin, Joseph;Armstrong, Lyle
通讯作者:
Armstrong, Lyle
DOI:
10.1084/jem.179.3.901
发表时间:
1994-03-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Boes B;Hengel H;Ruppert T;Multhaup G;Koszinowski UH;Kloetzel PM
通讯作者:
Kloetzel PM
DOI:
10.1056/nejmra1514296
发表时间:
2016-11-03
期刊:
The New England journal of medicine
影响因子:
--
作者:
Boussiotis VA
通讯作者:
Boussiotis VA
影响因子:
2.7
作者:
AKI, M;SHIMBARA, N;ICHIHARA, A
通讯作者:
ICHIHARA, A